HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transitional increase in growth fraction estimated by Ki-67 index after irradiation to human tumor in xenograft.

Abstract
The cell kinetics of human tumor cells (HSG) in vivo were estimated by Ki-67 index to analyze the biological behavior of quiescent cells after irradiation. The increment of Ki-67 index was dose-dependent up to 15 Gy irradiation. The Ki-67 index of tumor cells increased gradually from 35+/-5.0% before irradiation to 56+/-5.0% at day 5 after single irradiation of 15 Gy. Flow-cytometric study showed that the G1 population was decreased and the G2M population was elevated at day 5 after the irradiation. In fractionated irradiation, the time-course in the change of the Ki-67 index was similar to that of single irradiation. It was likely that tumor cells were recruited into the cell cycle from quiescent phase after irradiation. We consider the Ki-67 index to be a reliable indicator of growth fraction and useful to estimate the cell kinetics of irradiated tumors in vivo. The growth fraction estimated by Ki-67 index during radiotherapy is expected to be useful in predicting tumor response to radiation therapy.
AuthorsTakeo Takahashi, Takashi Nakano, Kuniyuki Oka, Koichi Ando
JournalAnticancer research (Anticancer Res) 2004 Jan-Feb Vol. 24 Issue 1 Pg. 107-10 ISSN: 0250-7005 [Print] Greece
PMID15015583 (Publication Type: Journal Article)
Chemical References
  • Ki-67 Antigen
Topics
  • Animals
  • Cell Division (radiation effects)
  • Dose-Response Relationship, Radiation
  • Flow Cytometry
  • G1 Phase (radiation effects)
  • Humans
  • Ki-67 Antigen (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Transplantation
  • Salivary Gland Neoplasms (metabolism, pathology, radiotherapy)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: